After Ligand Pharmaceuticals hired John Higgins as its new CEO in January 2007 , Third Point Management invested in the biotech firm .
Was able to cut Third Point Management 's losses .
After Ligand Pharmaceuticals hired John Higgins as its new CEO in January 2007 , Third Point Management invested in the biotech firm and was able to cut its losses .